Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study
- Published on 01/31/2025
- Reading time: 4 min.
Cho Soo-Kyung 1,2, Han Jung-Yong 1,2, Jeon Yena 3, You Seung-Hun 4, Jung Sun-Young 4, Jang Eun Jin 5, Sung Yoon-Kyoung 1,2
1 https://ror.org/04n76mm80 Department of Rheumatology Hanyang University Hospital for Rheumatic Diseases 04763 Seoul South Korea
2 https://ror.org/046865y68 Hanyang University Institute for Rheumatology Research Seoul South Korea
3 https://ror.org/040c17130 Department of Statistics Kyungpook National University Daegu South Korea
4 https://ror.org/01r024a98 College of Pharmacy Chung-Ang University Seoul South Korea
5 https://ror.org/04wd10e19 Department of Data Science Andong National University Andong South Korea
Abstract
Background To investigate cancer incidence and the potential influence of immunosuppressive agents in Korean systemic lupus erythematosus (SLE) patients.
Methods We conducted a retrospective analysis utilizing data from the Korea Healthcare Bigdata Linked Platform, which integrated the National Central Cancer Registry and National Health Insurance Service databases covering the period 2008–2017. Incidence rates (IRs) per 10,000 person-years (PYs)...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Rheumatology
Receive our newsletter to stay up to date with the latest news in Rheumatology
